KimberlyMcBennettMDMD, PhD

PubMed

• Impact of elexacaftor/tezacaftor/ivacaftor on lipid and fat-soluble vitamin levels and association with body mass index.
  Patel, T., Schindler, T., Minich, N., Malay, S., Kutney, K., McBennett, K., Sankararaman, S., Sundaram, K.> ;Pediatric Pulmonology. 2024 Mar 1
• 3 citations
  Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations.
  Kimberly A McBennett, Pamela B Davis> ;Clinics in Chest Medicine. 2022 Dec 1
• 4 citations
  Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapies.
  Kimberly McBennett, Christina J MacAskill, Elise Keshock, Maryam Ghadimi Mahani, Jaime Mata, Alexander J Towbin, Senthilkumar Sankararaman, Mitchell L Drumm, Xin Yu, C...> ;Journal of Cystic Fibrosis. 2022 Mar 1
• 48 citations
  Increasing life expectancy in cystic fibrosis: Advances and challenges.
  Kimberly McBennett, Pamela B. Davis, Michael W. Konstan> ;Pediatric Pulmonology. 2021 Nov 11
• 8 citations
  Rapid B1-Insensitive MR Fingerprinting for Quantitative Kidney Imaging.
  Christina J MacAskill, Michael Markley, Susan Farr, Ashlee Parsons, Jacob R Perino, Kimberly McBennett, Katherine Kutney, Mitchell L. Drumm, Nicole Pritts, Mark A. Gri...> ;Radiology. 2021 Jun 8
• 29 citations
  Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
  Katherine Kutney, Shannon B. Donnola, Christopher A Flask, Rose Gubitosi-Klug, MaryAnn O'Riordan, Kimberly McBennett, Thomas J Sferra, Beth Kaminski> ;World Journal of Hepatology. 2019 Dec 27
• 19 citations
  Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3
  Daniel R. McHugh, Calvin U. Cotton, Fraser J. Moss, Megan Vitko, Dana M. Valerio, Thomas J. Kelley, Shuyu Hao, Anjum Jafri, Mitchell L. Drumm, Walter F. Boron, Robert ...> ;American Journal of Physiology. Gastrointestinal and Liver Physiology. 2018 Nov 1
• 15 citations
  Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients.
  Shannon B. Donnola, Elliott C. Dasenbrook, David Weaver, Lan Lu, Karishma Gupta, Anjali Prabhakaran, Xin Yu, James F. Chmiel, Kimberly McBennett, Michael W. Konstan, M...> ;Journal of Cystic Fibrosis. 2017 Mar 1
• 7 citations
  Calcineurin-inhibitor induced pain syndrome in a lung transplant patient.
  Sandeep Sahay, Kimberly McBennett, Titus Sheers> ;Transplant International. 2013 Aug 1
• Join now to see all

Journal Articles

• Calcineurin-inhibitor induced pain syndrome in a lung transplant patient  
  Sahay, S., McBennett, K., Sheers, T., Transplant International, 1/1/2013
• Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats  
  Disshon, K.A. and Dluzen, D.E., Brain Research, 1/1/2000
• Estrogen modulates responses of striatal dopaminergic neurons to MPP+: Evaluations using in vitro and in vivo techniques  
  Arvin, M., Fedorkova, L., Disshon, K.A., Dluzen, D.E., and Leipheimer, R.E., Brain Research, 1/1/2000
• Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: Influence of estrogen  
  Disshon, K.A., and Dluzen, D.E., Brain Research, 1/1/1999
• Inhibition of striatal dopamine transporter activity by 17B-estradiol  
  Disshon, K.A., Boja, J.W., and Dluzen, D.E., European Journal of Pharmacology, 1/1/1998
• Estrogen as a neuromodulator of MPTP-induced neurotoxicity: Effects upon striatal dopamine release  
  Disshon, K.A., and Dluzen, D.E., Brain Research, 1/1/1997
• Join now to see all

Books/Book Chapters

• Recent Advances in Neurodegenerative Disorders 
  Chapter: Estrogen as a modulator of striatal dopaminergic neurotoxicity. 
  Page 149 - 192Dluzen, D.E., Disshon, K.A. and McDermott, J.L.Editors: J. Marwah, H. Teitelbaum.Prominent Press, Scottsdale1998

Abstracts/Posters

• A case of a Cystic Fibrosis patient with rapidly progressive colon cancer.
  Mister A; McBennett K, 21st Annual NEOUCOM Internal Medicine Research Day, Rootstown, OH, 1/1/2011
• Treating fungal endocarditis: Candida albicans endocarditis in a 45 year old Cystic Fibrosis patient.
  Wheeler D; McBennett K; Tan M, American College of Physicians Ohio Chapter, Columbus, OH, 1/1/2011
• 34 year old male with joint pains.
  Sahay, S., Murnane, L., McBennett, K., Sheers, T, 24th Annual North American Cystic Fibrosis Conference, 10/29/2010
• A Case of Colon Cancer in a 43-year-old Patient with Cystic Fibrosis. Clinical consultation presentation.
  McBennett, K.A, Singh, C., Sheers, T.G., 23rd Annual North American Cystic Fibrosis Conference, 10/17/2009
• Diagnosis of Multiple Sclerosis in an Elderly African American male.
  Younis, B. and McBennett, K, AGMC Post-graduate Day, 6/1/2009
• Use of a nutrition assessment score: Implications for CF care.
  Phillips, S., Spoonhower, K., McBennett, K., Powers, M., Nardecchia, M., Fenton, C., Kraynack, N., Pediatric Pulmonology, 1/1/2008
• Implementation of a nutrition scoring system to uniformly identify nutrition risk categories in children and adults with CF.
  Phillips, S.G., Powers, M., Koenig, M., McBennett, K., Collins, E., Fenton, C., Nardecchia, M., Kraynack, N.C., Pediatric Pulmonology, 1/1/2007
• Estrogen reduces MPP+-evoked striatal dopamine release in female, but not male rats.
  Disshon, K.A. and Dluzen, D.E., Society for Neuroscience Abstracts; Society for Neuroscience (SFN) National Conference, Los Angeles, CA, 1/1/1998
• Use of in vitro superfusion to assess the dynamics of striatal dopamine transporters: Effects of estrogen and nomifensine.
  Disshon, K.A., and Dluzen, D.E., Society for Neuroscience Abstracts; SFN National Conference, New Orleans, LA, 1/1/1997
• Interactive effects of estrogen and MPP+ upon corpus striatal dopamine release.
  Disshon, K.A. and Dluzen, D.E., Society for Neuroscience Abstracts; SFN National Conference, Washington, DC, 1/1/1996
• Join now to see all

Lectures

• Internal Medicine Grand Rounds: "Lifestyle Medicine." 
  Akron General Medical Center - 4/17/2013
• "Guidelines for Vitamin D Testing and Treatment Internal Medicine Update" 
  5/3/2012
• "Contraception" 
  1/1/2012
• "Cystic Fibrosis Throughout the Lifespan" 
  1/5/2011
• "The Need for Novel Delivery Systems for Antibiotics and the Challenges in Cystic Fibrosis." 
  Akron General Medical Center/ Austen BioInnovation Institute in Akron - 6/23/2010
• "Palliative Care in Cystic Fibrosis" 
  6/15/2010
• Keynote Speaker: "Leadership Skills" 
  1/1/2010
• "The Pelvic Exam and the Prostate Exam " 
  11/18/2009
• "Chronic Opioid Treatment of Non-Cancer Pain" 
  11/11/2009
• "Improving Patient Adherenc" 
  10/9/2009
• "Review of the Guidelines for Chronic Opioid Treatment of Non-Cancer Pain." 
  10/9/2009
• "Cystic Fibrosis" 
  9/16/2009
• "Fertility and Cystic Fibrosis." 
  4/18/2009
• "Update on Cystic Fibrosis" 
  10/26/2007
• Join now to see all